Pharma Focus Asia

Previous Issue - Issue 20

ahhm-current-issue

Issue 20 | 2014

Issue 20

PREVIOUS ISSUE

Strategy

Risk Management of Contamination

Prevention or cure?

These are very interesting exciting and challenging times in the world of pharmaceutical products companies and regulatory bodies There is a very valid argument that the pharmaceutical industry has some vital decisions to make regarding its future particularly with about outsourcing production and the introduction of new technologies Recent trends...

Non-Clinical Drug Development in Asia

A literature review and landscape assessment

Nonclinical development costs activities including drug discovery biology research chemistry research preclinical continues to account for a large percentage of overall drug Research and Development RD costs The Pharmaceutical Research and Manufacturers of America PhRMA estimated that in US billion or per cent of overall RD costs are attributed t...

Treating Neglected Diseases

The Role of Orphan Drugs

At the Institute for OneWorld Health we are pioneering an innovative approach to developing the drugs most needed to treat neglected diseases in the newly industrialising and nonindustrialised worldOn August the Government of India approved our first drug Paromomycin IM Injection to provide a new treatment for visceral leishmaniasis Paromomyc...

Research & Development

Developing New Vaccines

Developing New Vaccines

Edward Jenners work in developing the worlds first smallpox vaccine in the s demonstrated that it was possible to protect the general population from major threats to public health and vaccine development aimed at combating the major concerns of the day has continued ever since There have been many successes and vaccines are now available to immuni...

magazine-slider-image